- Conditions
- Alzheimer's Disease
- Interventions
- donezepil (Aricept)
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 55 Years to 90 Years
- Enrollment
- 38 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2007
- U.S. locations
- 2
- States / cities
- New Haven, Connecticut • Albany, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Alzheimer's Disease
- Interventions
- placebo, donepezil, ABT-126
- Drug
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Eligibility
- 55 Years to 90 Years
- Enrollment
- 438 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 8
- States / cities
- Delray Beach, Florida • Tampa, Florida • West Palm Beach, Florida + 5 more
- Conditions
- Cognition Disorders
- Interventions
- donepezil, Placebo
- Drug
- Lead sponsor
- National Institute on Aging (NIA)
- NIH
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2007
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Traumatic Brain Injury, Memory Deficits
- Interventions
- Donepezil, Placebo
- Drug
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2024
- U.S. locations
- 4
- States / cities
- Indianapolis, Indiana • Charlestown, Massachusetts • Elkins Park, Pennsylvania + 1 more
- Conditions
- Ischemic Stroke
- Interventions
- donepezil, placebo
- Drug
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 2
- States / cities
- Warren, Ohio • Pittsburgh, Pennsylvania
- Conditions
- Autism Spectrum Disorder
- Interventions
- Melatonin and Donepezil, Placebo
- Drug · Other
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- 4 Years to 17 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 1
- States / cities
- Stony Brook, New York
- Conditions
- Alzheimer Disease
- Interventions
- Placebo, SAM-531 1.5 mg, SAM-531 3.0 mg, SAM-531 5.0 mg, Donepezil
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 526 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 37
- States / cities
- Phoenix, Arizona • Costa Mesa, California • Fresno, California + 28 more
- Conditions
- Wound Heal
- Interventions
- Donepezil, Placebo oral tablet, Topical Zinc Oxide
- Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 20 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Easton, Maryland
- Conditions
- Parkinson Disease
- Interventions
- Donepezil
- Drug
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- NIH
- Eligibility
- Not listed
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Memory
- Interventions
- Donepezil, Placebos
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 55 Years to 90 Years
- Enrollment
- 198 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2000 – 2007
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Genetic Risk for Alzheimer's Disease
- Interventions
- donepezil HCL, Placebo
- Drug
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 60 Years to 75 Years
- Enrollment
- 89 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2021
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Dementia, Alzheimer's Disease
- Interventions
- Rasagiline
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 45 Years to 90 Years
- Enrollment
- 376 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2004
- U.S. locations
- 31
- States / cities
- Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 24 more
- Conditions
- Alzheimer's Disease
- Interventions
- Donepezil, AZD3480
- Drug
- Lead sponsor
- Targacept Inc.
- Industry
- Eligibility
- 60 Years to 85 Years
- Enrollment
- 386 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 3
- States / cities
- Phoenix, Arizona • Brooksville, Florida • Hallandale, Florida
- Conditions
- Down Syndrome, Cognitive Dysfunction
- Interventions
- Aricept (Donepezil hydrochloride), Placebo
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 6 Years to 10 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 2
- States / cities
- San Antonio, Texas • Herndon, Virginia
- Conditions
- Severe Alzheimer's Disease
- Interventions
- Donepezil Hydrochloride (Aricept)
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 50 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2008
- U.S. locations
- 1
- States / cities
- Toledo, Ohio
- Conditions
- Alzheimer Disease
- Interventions
- Placebo, BI 409306, Donepezil
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 55 Years and older
- Enrollment
- 329 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 10
- States / cities
- Sherman Oaks, California • Orlando, Florida • West Palm Beach, Florida + 7 more
- Conditions
- Cognitive Dysfunction, Memory Impairment
- Interventions
- Donepezil 5 mg, Placebo
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 75 Years · Female only
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 278
- States / cities
- Anaheim, California • Antioch, California • Baldwin Park, California + 206 more
- Conditions
- Skin Irritation, Sensitization
- Interventions
- Donepezil TDS, Vehicle TDS
- Drug
- Lead sponsor
- Corium, Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 256 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2018
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Lincoln, Nebraska
- Conditions
- Cognitive Impairment
- Interventions
- Aricept
- Drug
- Lead sponsor
- Eisai Limited
- Industry
- Eligibility
- 25 Years to 70 Years
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 2
- States / cities
- Maywood, Illinois • New York, New York
- Conditions
- Alzheimer's Disease
- Interventions
- ASP0777, Placebo
- Drug
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 2
- States / cities
- San Diego, California • Hallandale, Florida
- Conditions
- Alzheimer's Disease
- Interventions
- PF-03654746, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 55 Years to 85 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 2
- States / cities
- Wichita, Kansas
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Donepezil, placebo
- Drug
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Alzheimer's Disease
- Interventions
- SUVN-502, Placebo, Donepezil, Memantine
- Drug
- Lead sponsor
- Suven Life Sciences Limited
- Industry
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 564 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 71
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Costa Mesa, California + 56 more
- Conditions
- Alzheimer's Disease
- Interventions
- PRX-03140, Donepezil, Placebo
- Drug
- Lead sponsor
- Epix Pharmaceuticals, Inc.
- Industry
- Eligibility
- 50 Years to 90 Years
- Enrollment
- 236 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2008
- U.S. locations
- 33
- States / cities
- Phoenix, Arizona • Tucson, Arizona • National City, California + 28 more